Workflow
mRNA medicines
icon
Search documents
Jim Cramer’s Game Plan: 19 Stocks in Focus
Insider Monkey· 2026-02-09 10:50
Economic Outlook - The upcoming employment report from the Labor Department is crucial, with expectations of weakness that could allow the Federal Reserve to cut rates later this year, positively impacting sectors like housing, autos, and construction [2][4] - Interest rates have been rising, indicating a need for a weak labor report to sustain stock market growth [2] Stock Market Performance - The Dow Jones Industrial Average has crossed 50,000, marking significant wealth creation for persistent investors over the past 44 years [3] - Moderna, Inc. has been highlighted as a strong performer, with a nearly 50% increase in January, recovering from a 95% decline from its peak in 2021 [9] Company Focus: Moderna, Inc. - Moderna is recognized for its mRNA medicines and vaccines, with ongoing developments in personalized cancer vaccines, although it remains unprofitable [9][10] - The company is expected to return to revenue growth in 2026, which is a significant development for investors [9] Company Focus: Agnico Eagle Mines Limited - Agnico Eagle is noted as the second-largest gold miner globally, with a strong recommendation to invest in gold stocks due to limited supply growth [11][12] - The company operates primarily in Canada, which is favorable for business, and gold prices have recently surpassed $5,400 an ounce, indicating a bullish outlook for the gold market [12]
Moderna to complete US mRNA manufacturing network with $140 million investment
Reuters· 2025-11-19 13:44
Moderna said on Wednesday it would now operate full end-to-end manufacturing for its mRNA medicines in the U.S., marking a major step in strengthening the company's domestic production network. ...
Moderna Expands U.S. Manufacturing with Onshoring of Drug Product Capabilities
Accessnewswire· 2025-11-19 12:00
New capabilities strengthen U.S. production, completing Moderna's domestic end-to-end mRNA manufacturing network More than $140 million investment will create hundreds of highly skilled biomanufacturing jobs CAMBRIDGE, MA / ACCESS Newswire / November 19, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced the expansion of its U.S. manufacturing capabilities with the onshoring of Drug Product manufacturing to its existing Moderna Technology Center ("MTC") in Norwood, Massachusetts. Through this strategic onsh ...